Drug Type Small molecule drug |
Synonyms |
Target |
Action antagonists |
Mechanism D1 receptor antagonists(Dopamine D1 receptor antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Movement Disorders | Preclinical | United Kingdom | 25 May 1999 | |
Unspecified drug dependence | Preclinical | United Kingdom | 25 May 1999 | |
Schizophrenia | Preclinical | Denmark | - | |
Sleep Wake Disorders | Preclinical | United Kingdom | - | - |
Substance-Related Disorders | Preclinical | United Kingdom | - | - |